However, H2R blockers reduce the production of TNF‐α, IL‐10, IL‐15, and IFN‐γ inflammatory mediators in CRC mouse isogenic models, although the precise mechanism underlying these immune effects remains unclear [354]. The gene discussed is IFNG; the disease is colorectal carcinoma.